Alcaligenes xylosoxidans endocarditis of a prosthetic valve and pacemaker: In a 62-year-old woman

Texas Heart Institute Journal

Volumn 40, Issue 1, 2013, Pages 95-98

  Sawant, Abhishek C ^a   Srivatsa, Sanjay S ^a   Castro, Luis J ^b  

^a Neurosciences Critical Care Units   (United States)

^b SEQUOIA HOSPITAL   (United States)

Author keywords

Alcaligenes drug effects; Anti bacterial agents therapeutic use; Artificial microbiology; Bacteremia complications diagnosis drug therapy etiology; Bacterial diagnosis ultrasonography; Endocarditis; Gramnegative bacterial infections complications etiology; Heart valve prosthesis; Opportunistic infections epidemiology; Pacemaker; Treatment outcome

Indexed keywords

AMIKACIN; CEFTAZIDIME; COTRIMOXAZOLE; GENTAMICIN; INOTROPIC AGENT; MEROPENEM; METRONIDAZOLE; PIPERACILLIN PLUS TAZOBACTAM; RIFAMPICIN; TOBRAMYCIN; VANCOMYCIN;

ACHROMOBACTER XYLOSOXIDANS; ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; AORTA STENOSIS; AORTA VALVE PROSTHESIS; AORTA VALVE REPLACEMENT; AORTIC ROOT SURGERY; ARTICLE; ARTIFICIAL HEART PACEMAKER; ARTIFICIAL VENTILATION; BACTERIAL VIRULENCE; BLOOD CULTURE; BRADYCARDIA; CASE REPORT; CELLULITIS; CLOSTRIDIUM DIFFICILE INFECTION; COMORBIDITY; DEBRIDEMENT; DEVICE INFECTION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; GRAM NEGATIVE SEPSIS; HEART FAILURE; HOMOGRAFT VALVED CONDUIT; HOSPITAL READMISSION; HUMAN; HYPOTENSION; INTRAAORTIC BALLOON PUMP; MINIMUM INHIBITORY CONCENTRATION; MITRAL VALVE REGURGITATION; MITRAL VALVE REPLACEMENT; PACEMAKER LEAD INFECTION; PROSTHETIC VALVE ENDOCARDITIS; RECURRENT INFECTION; RESPIRATORY FAILURE; SEPTIC SHOCK; TRANSESOPHAGEAL ECHOCARDIOGRAPHY;

ALCALIGENES/DRUG EFFECTS; ANTI-BACTERIAL AGENTS/THERAPEUTIC USE; BACTEREMIA/COMPLICATIONS/DIAGNOSIS/DRUG THERAPY/ETIOLOGY; ENDOCARDITIS, BACTERIAL/DIAGNOSIS/ULTRASONOGRAPHY; GRAM-NEGATIVE BACTERIAL INFECTIONS/COMPLICATIONS/ETIOLOGY; HEART VALVE PROSTHESIS; OPPORTUNISTIC INFECTIONS/EPIDEMIOLOGY; PACEMAKER, ARTIFICIAL/MICROBIOLOGY; TREATMENT OUTCOME;

ALCALIGENES; ANTI-BACTERIAL AGENTS; DEVICE REMOVAL; DRUG RESISTANCE, BACTERIAL; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; ENDOCARDITIS, BACTERIAL; FEMALE; GRAM-NEGATIVE BACTERIAL INFECTIONS; HEART VALVE PROSTHESIS; HUMANS; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PACEMAKER, ARTIFICIAL; PROSTHESIS-RELATED INFECTIONS; RECURRENCE; REOPERATION; TREATMENT OUTCOME; VIRULENCE;

EID: 84877717644     PISSN: 07302347     EISSN: 15266702     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Bergey DH, Holt JG. Bergey's manual of determinative bacteriology. 9th ed. Philadelphia: Lippincott Williams & Wilkins; 2000. p. 75.
2. Yabuuchi E, Oyama A. Achromobacter xylosoxidans n. sp. from human ear discharge. Jpn J Microbiol 1971;15(5):477-81.
3. Kim MJ, Bancroft E, Lehnkering E, Donlan RM, Mascola L. Alcaligenes xylosoxidans bloodstream infections in outpatient oncology office. Emerg Infect Dis 2008;14(7):1046-52.
4. Reverdy ME, Freney J, Fleurette J, Coulet M, Surgot M, Marmet D, Ploton C. Nosocomial colonization and infection by Achromobacter xylosoxidans. J Clin Microbiol 1984;19 (2):140-3.
5. Beringer PM, Appleman MD. Unusual respiratory bacterial flora in cystic fibrosis: microbiologic and clinical features. Curr Opin Pulm Med 2000;6(6):545-50.
6. Manfredi R, Nanetti A, Ferri M, Chiodo F. Bacteremia and respiratory involvement by Alcaligenes xylosoxidans in patients infected with the human immunodeficiency virus. Eur J Clin Microbiol Infect Dis 1997;16(12):933-8.
7. Gomez-Cerezo J, Suarez I, Rios JJ, Pena P, Garcia de Miguel MJ, de Jose M, et al. Achromobacter xylosoxidans bacteremia: a 10-year analysis of 54 cases. Eur J Clin Microbiol Infect Dis 2003;22(6):360-3.
8. Ramos JM, Fernandez-Roblas R, Garcia-Ruiz P, Soriano F. Meningitis caused by Alcaligenes (Achromobacter) xylosoxidans associated with epidural catheter. Infection 1995;23(6): 395-6.
9. Ahn Y, Kim NH, Shin DH, Park OY, Kim W, Jeong MH, et al. Pacemaker lead endocarditis caused by Achromobacter xylosoxidans. J Korean Med Sci 2004;19(2):291-3.
10. Duggan JM, Goldstein SJ, Chenoweth CE, Kauffman CA, Bradley SF. Achromobacter xylosoxidans bacteremia: report of four cases and review of the literature. Clin Infect Dis 1996; 23(3):569-76.
11. Aisenberg G, Rolston KV, Safdar A. Bacteremia caused by Achromobacter and Alcaligenes species in 46 patients with cancer (1989-2003). Cancer 2004;101(9):2134-40.
12. Li JS, Sexton DJ, Mick N, Nettles R, Fowler VG Jr, Ryan T, et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 2000;30(4):633-8.
13. Arroyo JC, Jordan W, Lema MW, Brown A. Diversity of plasmids in Achromobacter xylosoxidans isolates responsible for a seemingly common-source nosocomial outbreak. J Clin Microbiol 1987;25(10):1952-5.
14. Glupczynski Y, Hansen W, Freney J, Yourassowsky E. In vitro susceptibility of Alcaligenes denitrificans subsp. xylosoxidans to 24 antimicrobial agents. Antimicrob Agents Chemother 1988;32(2):276-8.
15. Ahmed MS, Nistal C, Jayan R, Kuduvalli M, Anijeet HK. Achromobacter xylosoxidans, an emerging pathogen in catheter-related infection in dialysis population causing prosthetic valve endocarditis: a case report and review of literature. Clin Nephrol 2009;71(3):350-4.